Back to Search
Start Over
Radiosynthesis of O-(1-[ 18 F]fluoropropan-2-yl)-O-(4-nitrophenyl)methylphosphonate: A novel PET tracer surrogate of sarin.
- Source :
-
Journal of labelled compounds & radiopharmaceuticals [J Labelled Comp Radiopharm] 2018 Dec; Vol. 61 (14), pp. 1089-1094. Date of Electronic Publication: 2018 Nov 04. - Publication Year :
- 2018
-
Abstract
- O-(1-Fluoropropan-2-yl)-O-(4-nitrophenyl) methylphosphonate is a reactive organophosphate ester (OP) developed as a surrogate of the chemical warfare agent sarin that forms a similar covalent adduct at the active site serine of acetylcholinesterase. The radiolabeled O-(1-[ <superscript>18</superscript> F]fluoropropan-2-yl)-O-(4-nitrophenyl) methylphosphonate ([ <superscript>18</superscript> F] fluorosarin surrogate) has not been previously prepared. In this paper, we report the first radiosynthesis of this tracer from the reaction of bis-(4-nitrophenyl) methylphosphonate with 1-[ <superscript>18</superscript> F]fluoro-2-propanol in the presence of DBU. The 1-[ <superscript>18</superscript> F]fluoro-2-propanol was prepared by reaction of propylene sulfite with Kryptofix 2.2.2 and [ <superscript>18</superscript> F] fluoride ion. The desired tracer O-(1-[ <superscript>18</superscript> F]fluoropropan-2-yl)-O-(4-nitrophenyl) methylphosphonate was obtained in a >98% radiochemical purity with a 2.4% ± 0.6% yield (n = 5, 65 minutes from start of synthesis) based on starting [ <superscript>18</superscript> F] fluoride ion and a molar activity of 49.9 GBq/μmol (1.349 ± 0.329 Ci/μmol, n = 3). This new facile radiosynthesis routinely affords sufficient quantities of [ <superscript>18</superscript> F] fluorosarin surrogate in high radiochemical purity, which will further enable the tracer development as a novel radiolabeled OP acetylcholinesterase inhibitor for assessment of OP modes of action with PET imaging in vivo.<br /> (© 2018 John Wiley & Sons, Ltd.)
Details
- Language :
- English
- ISSN :
- 1099-1344
- Volume :
- 61
- Issue :
- 14
- Database :
- MEDLINE
- Journal :
- Journal of labelled compounds & radiopharmaceuticals
- Publication Type :
- Academic Journal
- Accession number :
- 30347484
- Full Text :
- https://doi.org/10.1002/jlcr.3688